anthem-biosciences-listing-on-bse-nse-anil-singhvi-view-target-stoploss-price-hold-or-sell-short-long-term-investors-advice-issue-price

Anthem Biosciences Listing Preview: Anthem Biosciences Ltd., which is a fully integrated operations encompassing drug discovery, development, and manufacturing processes, is set to list on BSE and NSE today (Monday, July 21, 2025).
The offers for sale IPO, which opened on July 14 and closed on July 16, had an issue price of Rs 570 per share.
Zee Business managing editor, Anil Singhvi, is expecting a strong list for the company at an above-Rs 700 price.
The market guru says that the company can list in the range of Rs 715-Rs 730.
Long-term perspective
The market wizard advises applying for good listing gains and long term with 2-3 years of perspective.
To short-term investors, he advises holding with a stoploss of Rs 675.
Singhvi says that long-term investors must hold the Anthem Biosciences stock in their portfolio.